14.97
0.88 (6.25%)
0.88 (6.25%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 1,046,319 |
|
|||||
News | (1) | ||||||
Day High | 15.25 | Low High |
|||||
Day Low | 13.77 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Sensus Healthcare Inc | SRTS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
14.31 | 13.77 | 15.25 | 14.97 | 14.09 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
7,014 | 1,046,319 | $ 14.71 | $ 15,394,077 | - | 3.21 - 15.25 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:58:41 | 10 | $ 14.97 | USD |
Sensus Healthcare Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 247.84M | 16.56M | 13.83M | $ 27.04M | $ 16.45M | 0.24 | 9.30 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | -17.87k | 29.60% |
Sensus Healthcare News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRTS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 12.58 | 15.25 | 12.0252 | 14.24 | 776,383 | 2.39 | 19.0% |
1 Month | 9.16 | 15.25 | 9.0804 | 12.40 | 384,185 | 5.81 | 63.43% |
3 Months | 8.92 | 15.25 | 7.45 | 10.68 | 237,068 | 6.05 | 67.83% |
6 Months | 8.16 | 15.25 | 6.81 | 10.01 | 308,960 | 6.81 | 83.46% |
1 Year | 3.69 | 15.25 | 3.21 | 8.94 | 231,091 | 11.28 | 305.69% |
3 Years | 5.71 | 15.25 | 1.7603 | 6.90 | 133,983 | 9.26 | 162.17% |
5 Years | 5.12 | 15.25 | 1.7603 | 6.86 | 95,143 | 9.85 | 192.38% |
Sensus Healthcare Description
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated primarily from customers in the United States. |